Abbott Laboratories http://www.globalpost.com/taxonomy/term/27547/all en UPDATE 4-Abbott results bode well for spun-off AbbVie http://www.globalpost.com/dispatch/news/thomson-reuters/130123/update-3-abbott-results-bode-well-spun-abbvie <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Abbott 2013 profit forecast slightly above Street view</p> <p>* Humira sales growth a good sign for AbbVie</p> <p>* Abbott shares slip; AbbVie shares rise 3.8 percent</p> <p>By Ransdell Pierson</p> <p>Jan 23 (Reuters) - AbbVie Inc, the new branded pharmaceuticals company spun off by Abbott Laboratories Inc , is off to a good start, judging by fourth-quarter sales of arthritis drug Humira and other products in its medicine chest.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130123/update-3-abbott-results-bode-well-spun-abbvie" target="_blank">read more</a></p> Abbott Laboratories Abbott Laboratories Inc AbbVie Inc Entertainment Health Hospitality Medicine Pharmacology Thomson Reuters Wed, 23 Jan 2013 19:30:55 +0000 5738461 at http://www.globalpost.com Abbott buying Chile generic drug maker for $3.3 bn http://www.globalpost.com/dispatch/news/afp/140516/abbott-buying-chile-generic-drug-maker-33-bn <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>US drug maker Abbott Laboratories said Friday it is buying Chilean generics manufacturer CFR Pharmaceuticals in a $3.3 billion deal to build its presence Latin America.</p> <p>The transaction establishes Abbott as one of the 10 biggest pharma companies in Latin America, where the pharmaceutical market is expected to grow to $124 billion by 2018 from $73 billion in sales this year.</p> <p>Abbott said CFR's assets will bolster its portfolio of treatments in key areas, including women's health, central nervous system, cardiovascular and respiratory diseases.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2014.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/140516/abbott-buying-chile-generic-drug-maker-33-bn" target="_blank">read more</a></p> Abbott Laboratories Abbott Laboratories Pharmaceutical sciences Pharmacology AFP Fri, 16 May 2014 14:04:19 +0000 6148702 at http://www.globalpost.com Abbott to buy Latin American drugmaker CFR in $2.9 billion deal http://www.globalpost.com/dispatch/news/thomson-reuters/140516/abbott-buy-latin-american-drugmaker-cfr-29-billion-deal-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Caroline Humer</p> <p>(Reuters) - Abbott Laboratories &lt;ABT.N&gt; said on Friday it would acquire Chile's CFR Pharmaceuticals SA &lt;CFR.SN&gt; in a $2.9 billion deal that will more than double its branded generic drugs business in the fast-growing Latin American market.</p> <p>This is the first deal for Abbott since it split into two businesses and spun off its blockbuster rheumatoid arthritis drug in a new company, AbbVie Inc &lt;ABBV.N&gt;, last year and comes at a time when health mergers have surged.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2014.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/140516/abbott-buy-latin-american-drugmaker-cfr-29-billion-deal-0" target="_blank">read more</a></p> Abbott Laboratories Abbott Laboratories Business Chilean peso Health Labor Law Social Issues Technology Thomson Reuters Fri, 16 May 2014 16:17:20 +0000 6148808 at http://www.globalpost.com Abbott Laboratories to spend about $2.9B on Latin American drugmaker CFR Pharmaceuticals http://www.globalpost.com/dispatch/news/the-canadian-press/140517/abbott-laboratories-spend-about-29b-latin-american-drugmaker <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> The Canadian Press </div> </div> </div> <!--paging_filter--><p>NORTH CHICAGO, Ill. - Abbott Laboratories will spend about $2.9 billion to broaden its reach in Latin America with the acquisition of branded generic drugmaker CFR Pharmaceuticals.</p> <p>Abbott makes infant formula like Similac as well as medical devices and drugs. The North Chicago, Illinois, company said Friday the deal will expand its presence in several fast-growing markets, especially with branded generic drugs.</p> <p>An Abbott spokesman said generic drugs with brand names are preferred in many developing markets due to their reputation for quality and consistent supply.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.globalpost.com/terms-use#cp">Copyright 2014 Canadian Press.</a></p> <p>All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.</p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/the-canadian-press/140517/abbott-laboratories-spend-about-29b-latin-american-drugmaker" target="_blank">read more</a></p> Abbott Laboratories Abbott Laboratories Pharmaceutical sciences Pharmacology USD The Canadian Press Sat, 17 May 2014 17:05:19 +0000 6149399 at http://www.globalpost.com